US 8101584
Method and medicament for inhibiting the expression of a given gene
granted A61KA61K31/713A61K38/00
Quick answer
US patent 8101584 (Method and medicament for inhibiting the expression of a given gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/713, A61K38/00, A61P, A61P25/28